ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,230, issued on Nov. 18, was assigned to PARK STRATEGIC VENTURES LLC (Scottsdale, Ariz.).

"Peptides and methods of use thereof in treating uveitis" was invented by Indu Parikh (Durham, N.C.) and Ashish Bhatia (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure includes methods of treating ocular inflammation or inflammatory ocular conditions, such as uveitis. More specifically the present disclosure relates to inhibiting or reducing the release of inflammatory mediators from inflammatory cells by inhibiting the mechanism associated with the release of inflammatory mediators from granules in inflammatory cells. In this ...